Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design.
about
Receptor-binding domain-based subunit vaccines against MERS-CoVVaccines for Epidemic Infections and the Role of CEPIIdentification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1.Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice.A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike proteinMiddle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseSevere acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.Receptor usage and cell entry of porcine epidemic diarrhea coronavirusOptimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and DiseaseIdentification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines.Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus.Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein.Vaccines for the prevention against the threat of MERS-CoV.Middle East respiratory syndrome: current status and future prospects for vaccine development.Vaccines against Middle East respiratory syndrome coronavirus for humans and camels.Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infectionA recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection.Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses.Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike GlycoproteinCritical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen.A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoVHuman β-defensin 2 plays a regulatory role in innate antiviral immunity and is capable of potentiating the induction of antigen-specific immunity
P2860
Q26851979-ADA140DA-BDF3-45D4-8EEB-90A24A866CACQ29224804-242F7989-1243-4601-905E-6C63E9B126CBQ30371303-5D4DB934-C8B8-4030-B172-2C28FE7F8F55Q30378994-C0AD7C85-09DC-400A-8ACD-41FA62ED92B5Q30387699-0A658C6A-1CBE-467A-97A7-CD23E231B838Q30399700-244AEFA6-5AD0-464B-80AE-7C527373DD85Q30400066-4AF4BFF3-D409-46D2-B156-3652FBF223A5Q30402347-117E9D2E-55E6-4F07-9E9C-39EABA0DA48AQ34468689-D2A0AA80-4188-4FBE-86F3-484BD3B06B06Q35111000-F82259A9-105D-42D0-88B0-48CD6C49D312Q35641223-25CD73EA-0BCB-44BC-BB43-FBEBEA3B3A67Q35887626-C0C78E6B-D18C-4D67-8732-0B84C3B05B84Q36433987-04B18A4D-1905-4F6C-BBF8-F031C7CB5445Q37358618-E6CC1A2F-CA12-46A6-BBE4-A78C0EFB2053Q37434385-AEB9BF24-68C6-4E8A-90F7-0924646A46DFQ37512915-D1C40745-2C5E-4289-895F-07637C8678E3Q37560824-0C067E2D-FB06-4E3D-A9FC-DBF66A320666Q37717377-6876B50F-94E0-47E5-A4C6-C49D7E1A7B29Q38778044-10B7C9F1-4A44-482C-8672-0B0FB22F55C2Q38959242-461674E1-0CE7-4E27-A78F-BC90E7BD3C61Q38992327-4ECA4575-AA45-4E45-86BA-0E08C2B3655CQ39677274-7A86F050-AFF6-4D51-A442-761F6B1A144BQ40503787-E22EA7A5-073B-4C35-930F-4914D491F224Q40707492-1631BE1A-F1E3-4DDE-AF14-96D752BB3FF5Q41199088-DE1CE034-5156-459C-970D-459541863ADEQ47549528-5697AD5B-A23D-4B50-8F79-CF6375B3EBFEQ47607374-74E0F552-BC51-43C5-9BAA-A9BA97D909CFQ51730564-D78715AA-18F3-4A27-BD1E-92F47AC1FC60Q58693121-FEE457B6-B95F-4647-B46A-C2C13F38496BQ58795888-5F74A02A-C24C-46C2-8986-777363A27371
P2860
Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Searching for an ideal vaccine ...... ing in subunit vaccine design.
@ast
Searching for an ideal vaccine ...... ing in subunit vaccine design.
@en
Searching for an ideal vaccine ...... ing in subunit vaccine design.
@nl
type
label
Searching for an ideal vaccine ...... ing in subunit vaccine design.
@ast
Searching for an ideal vaccine ...... ing in subunit vaccine design.
@en
Searching for an ideal vaccine ...... ing in subunit vaccine design.
@nl
prefLabel
Searching for an ideal vaccine ...... ing in subunit vaccine design.
@ast
Searching for an ideal vaccine ...... ing in subunit vaccine design.
@en
Searching for an ideal vaccine ...... ing in subunit vaccine design.
@nl
P2093
P2860
P50
P1433
P1476
Searching for an ideal vaccine ...... ing in subunit vaccine design.
@en
P2093
Chien-Te K Tseng
Cuiqing Ma
Naru Zhang
Xinrong Tao
Yusen Zhou
P2860
P304
P356
10.1016/J.VACCINE.2014.08.086
P407
P577
2014-09-19T00:00:00Z